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Abstract

Oxidative stress plays a critical role in neurodegenerative diseases and spinal cord injuries. In
multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS), 3-nitrotyrosine (3-NY) positive
plaques have been observed, suggesting that peroxynitrite (ONOO') preferentially nitrates
proteins after reaction of nitric oxide (NO) with superoxide. Our studies show a differential NO
resistance between motor neurons and oligodendrocytes in that motor neurons are much more
sensitive to NO damage than are oligodendrocytes. Western blot analysis shows that 3-NY
formation correlates to cell death, indicating that peroxynitrite is the damaging agent, rather than
NO per se. Resistance to NO can be induced in motor neurons after exposure to low levels of
NO. When co-cultured, oligodendrocytescan bestow their resistance to motor neurons, and
results suggest that the protective mechanism is due to a factor, rather than a morphological
means. These findings elucidate the etiology of MS and the possible role of the heme
oxygenase- 1 pathway in the defense against this disease.

Introduction

Nitric oxide (NO) is a free radical gas and at low concentrations serves many
physiological functions, including cellular differentiation, neurotransmission, and signal
transduction (Packer et al. 2003). The concentrations at which these functions occur ranges fiom
50 to 500 nM. At high concentrations, NO is toxic and induces apoptosis in motor neurons. In
pathological situations, microglia and astrocytes can produce NO at concentrations beyond 1 pM.
Upon reaction with superoxide (023, peroxynitrite (ONOO'), a reactive nitrogenous species, is
produced (Pacher et al. 2007). Peroxynitrite preferentially nitrates proteins at tyrosine residues,
forming 3-nitrotyrosine(3-NY) (Bishop et al. 2006). 3-NY plaques have been found in patients
with multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), and spinal cord injuries
(Pacher et al. 2007).
In this study, motor neurons are primed for the cytotoxic dose of NO by induced adaptive
resistance (IAR),a process under which the cells are exposed to a low dose of NO (-25 nM/s)
prior to treatment (Bishop et al. 2009b). This mechanism of resistance is dependent on heme
oxygenase-1 (HO-1) in a motor neuron cell line (Bishop et al. 2004). Furthermore,
oligodendrocytes demonstrate a native resistance to NO at concentrations that are cytotoxic to
motor neurons. When grown in co-culture, oligodendrocytes can bestow their resistance to
motor neurons (Bishop et al. 2009a). This study investigates the implications of IAR and
differential NO sensitivity for therapy in MS.
Materials and Methods

Cell lines

The NSC-34 cell line, a fbsion of primary mouse spinal cord motor neurons with spinal
neuroblastoma cells, was used as the motor neuron model. Upon serum reduction from 10% to
2%, the NSC-34 cells become NSC-34D, a further differentiated version that have characteristics

of differentiated motor neurons, such as expression of NMDA receptors, and a limited ability to
divide (Eggett et al. 2000).
The M03.13 cell line, an immortalized human-human hybrid cell line was used as the
oligodendrocyte model. This line was created from the fusion of a 6-thioguanine resistant mutant
of the human rhabdomyosarcoma with adult human oligodendrocytes. These cells also
differentiate upon serum deprivation and have characteristics of mature primary
oligodendrocytes, including the expression of myelin basic protein, CNPase, proteolipid protein,
and 0 1 protein (McLaurin et al. 1995).
All cells were grown in a humidified 5% CO2 environment in 1:1 Dulbecco's modified
Eagle's medium (DMEM) without sodium pyruvate/HamtsF- 12 mixture, 1% non-essential animo
acids (NEAA), and 2% heat inactivated FBS.
Cell treatments

Motor neurons and oligodendrocytes were plated at the same density in six-well plates,
fed with 1 mL of media at the same temperature and pH and treated with a range of NO doses.
For treatment at "pretreatment" NO dose, the compound (2)- 1-[N-(2-arninoethy1)-N-(2-

arnrnonioethyl)amino]diazen- 1-ium- 1,2-diolate, DETA NONOate with a half life of 20 hours at
37°C was used. For treatment at "challenge" NO dose, the compound (2)-l-[N-[3-aminopropyll-

N-[4-(3-aminopropylammonio)butyl]-amino]1-ium-1,2-diolate, spennine NONOate with
a half life of 39 minutes at 37OC was used (Bishop et al. 2009a). The donors were prepared in
aqueous solutions at pH 10 and 4°C to prevent NO release. After a 1 hour treatment with the
prescribed NO donor, the media was changed to eliminate the NO donor. Cell counts were
performed 24 hours after NO treatment because the onset of maximal damage occurs at this time
(Bishop and Anderson 2005).

The induced adaptive

"pn~lrenlmenl"

resistance (IAR) protocol was
performed by treating the cells
with 10 pM DETA NONOate for 1
hour, refreshing the media with
motor neuron-spent media,
incubating for 2 hours, and
challenging them with 1 mM
sperrnine NONOate as in the
cytotoxic protocol (Figure 1).
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Figure 1. NO protocol
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oxygenase-1 inhibitor (Akins et al. 2004) and 1 mM uric acid, a peroxynitrite scavanger (Pacher
et al. 2007). These agents were tested alone and with NO donors to control for any toxicity with

the agents, themselves. For the oligodendrocyte media overlay treatment, 48 hour-old media
from the oligodendrocytes was transferred to six-wells containing motor neurons prior to NO
treatment. The oligodendrocyte-spent media contained no oligodendrocyte cells because the
cells are adherent to the plate. Trypsin was added to the spent media to determine whether a key
protein was being secreted by the oligodendrocytes.
Cell survival assay

Cell viability was determined by Trypan blue exclusion, intact morphology, and neurite
outgrowth. A minimum of 200 cells were counted from at least five randomly chosen fields.

Cell survival was calculated by dividing post-treatment totals by the post-treatment untreated cell
counts and multiplying by 100%.
Western blot

Dead cells were collected by centrifugation and combined with live cells of the same
treatment that were collected with lysis buffer. The cells were mechanically lysed with a 2 1
gauge syringe and preserved with protease inhibitor at -80°C. For western blot samples, the
protein concentrations were determined using the Bio-Rad DC Protein Assay. Cell lysates were
loaded with equal protein on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, run at
100 V for approximately 1.5 hours, and transferred onto nitrocellulose membranes for 2 hours at
80 V and 4°C. The blots were washed, blocked with 3% BSA, incubated with rabbit primary
anti-3-NY (1 :1000; Upstate Biotechnology 06-284) and developed by a colorimetric secondary
antibody (Bio-Rad 170-5052). A biotintylated broad range molecular weight marker (Bio-Rad
161-0319)was used and nitrated albumin (Sigma-Aldrich N8 159) was used as a positive control.
Analysis of the membranes was conducted in UN-SCAN IT gel densitometry software (Silk
Scientific).
Statistical analysis

Experiments were repeated a minimum of four times. The mean of the cell counts were
taken, and the SEM was calculated. The data was analyzed by a two-tailed t test and sigsicance
( p value) was determined. A value o f p < 0.01 was marked as significant.
Results

Peroxynitrite-mediated cell death and IAR in motor neurons

Cell treatments were performed and pictures were taken 24 hours post treatment (Figure
2). Cell counts are quantified in Figure 3. Motor neurons treated with 1 rnM spermine NONOate
(CT) had most cell death with a survival rate of < 10%. The morphology of the cells in the

cytotoxic treatment changed such that there is little neurite outgrowth. The uric acid (UA)
treatment and the addition of 10 p M DETA NONOate (PT) had little effect on the cells. The
addition of uric acid in the cytotoxic treatment (CT+UA) restored cell viability. Also,
pretreatment with a subtoxic dose, followed by exposure to the cytotoxic dose (IAR) saved the
motor neurons from cell death.
The cell counts reflect the pictures of selected

Figure 2. Motor neuron morphology
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Figure 3. Motor neuron cell counts

Figure 4. Western blot

1 molecular weight marker; 2 UT; 3 UA; 4 ZnPP;
5 PT; 6 CT; 7 CT+UA; 8 IAR; 9 IAR+ZnPP;
10 nitrated albumin (positive control)

demonstrated that CT had the most 3-NY formation when compared with the untreated (UT).
IAR+ZnPP had 1.4 times more 3-NY residues than UT. All other treatments had equal or less 3NY than the untreated (Figure 5).

Figure 5. Densitometry analysis: treatments compared to untreated (UT)
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Differential NO resistance in oligodendrocytes

Compared to motor neurons, oligodendrocytes are not as sensitive to NO damage (Figure

6). At the cytotoxic dose (high NO) nearly 80% of the oligodendrocytes survive, whereas there
Figure 6. Morphological differences between motor neurons and oligodendrocytes
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is less than 10% survival in motor neurons (Figure 7). At low NO dose, there is relatively no
change in either cell lines. To test whether the HO-1 pathway has a role in the native resistance
of the oligodendrocytes, zinc protoporphyrin-IX (ZnPP)was added as a heme oxygenase- 1
inhibitor. The control showed that ZnPP by itself is quite toxic, and when coupled with a high
dose of NO (CT+ZnPP), resistance in oligodendrocytes is turned off. However, the addition of
uric acid to the same treatment (CT+UA+ZnPP) restores viability, while using 4 rnM of spermine
NONOate (4XCT) results in only 37% cell survival (Figures 8 and 9).
Figure 7. Differential sensitivity to NO

-

i

loo
90

$
.-

s

80 7 0 ~

oligodendrocytes

40 1
30 1
201

I

NSC-34D

'L -*- . M03.13
_

~
0

motor neurons
Low

H~gh

NO flux

Figure 8. NO sensitivity in oligodendrocytes
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Figure 9. Oligodendrocyte cell counts

Increased motor neuron survival with oligodendrocyte aid

In previous studies by Bishop et al., co-culturing motor neurons with oligodendrocytes
showed that oligodendrocytes can bestow resistance on motor neurons (2009a). To determine
whether the oligodendrocytes were saving the motor neurons morphologically or by secreting a
Figure 10. Motor neuron survival with oligodendrocyte media overlay

factor key to resistance, oligodendrocyte-spentmedia was placed on motor neurons prior to
treatment. The media overlay showed in increase in motor neuron survival from 28% to 88%.
Addition of trypsin, which cleaves proteins at lysine and arginine residues except when either is
followed by a proline, resulted in a loss of resistance with survival of only 44% of the motor
neurons (Figure 10).
Discussion

The results from this study shows that NO toxicity in motor neurons and oligodendrocytes
is peroxynitrite-mediated. The addition of uric acid, a peroxynitrite scavenger, in the cytotoxic
treatment (CT+UA) saved the sensitive motor neurons from the cytotoxic dose (Figure 3).
Pictures of the cells demonstrate less neurite outgrowth, indicating that the motor neurons have
been induced to apoptosis (Bishop et al. 2006). However, at the low NO dose (PT), cell survival
remained high at 96%, suggesting NO is only h d l to motor neurons at high flux.
Induced adaptive resistance had a positive effect on motor neurons. The pretreatment of
the cells with low dose before exposure to the high dose allowed cell survival to reach 72%,
demonstrating that motor neurons can be induced to become resistant. The loss of resistance
upon addition of zinc protoporphyrin-IX showed that the HO-1 pathway plays a critical role in
resistance (Bishop et al. 2009b). Examination of 3-NY in the treatments revealed that cell death
is positively correlated with 3-NY formation, and that the abrogation of 3-NY is important in
therapy of diseases involving peroxynitrite-mediated cell death (Figure 5).
Furthermore, oligodendrocytes showed a native resistance to NO damage at the cytotoxic
dose used in this study. Using 4 times the cytotoxic dose resulted in 37% oligodendrocyte
survival, indicating that oligodendrocytes are sensitive to some degree, but are much more robust
than the motor neurons. The inhibition of HO- 1 by zinc protoporphyrin-IX showed a loss in
resistance, supporting the data from the motor neuron experiments that the metabolites of HO- 1

is necessary for the mitigation of 3-NY formation and subsequent cell death. In addition,
treatment with uric acid for oligodendrocytes in this treatment (CT+UA+ZnPP) demonstrated
again that cell death is peroxynitrite-mediated (Figure 9).
From co-culture studies by our lab, we have demonstrated that oligodendrocytes can lend
their native resistance to motor neurons (Bishop et al. 2009a). The oligodendrocytemedia
overlay experiment showed that oligodendrocytes share this resistance by secreting a factor,
rather than physically protecting the axons of the motor neurons. The difference in motor neuron
viability fiom CT in the control to CT in the experimental treatment is significant, suggesting that
the isolation of this factor has practical implications for drug development for MS. The trypsin
treatment of the oligodendrocyte-spent media verifies that a protein secreted by oligodendrocytes
is key to resistant activity (Figure 10).
Conclusion

Results from this study show that motor neurons are comparably more sensitive to NO
than are oligodendrocytes, and that the toxicity to NO is fiom peroxynitrite nitrating proteins and
affecting normal protein structure and function (Pacher et al. 2007). Moreover, inhibition of
HO-1 results in a detrimental loss of this native resistance in oligodendrocytes and induced
resistance in motor neurons by IAR Since the metabolites of HO-1 are anti-oxidants, the
oligodendrocytes may be secreting HO- 1, itself, or a protein with HO- 1 activity (Bishop et al.
2009a). The fact that media fiom oligodendrocytes contain a factor that is critical to motor
neuron viability to the cytotoxic dose has tremendous therapeutic implications on MS.
Identifying this unknown factor and understanding the mechanism by which protein nitration
leads to apoptosis are important in elucidating the etiology of MS.
Acknowledgement

I gratefully acknowledge Dr. Amy Bishop for her continual guidance and expertise.

Members of the lab, particularly Stephanie Jeffrey, Lorraine Smallwood, Kimberly Green-Hobbs,
and James Anderson, contributed to these studies. I thank Dr. Neil R. Cashman for his kind gift
of the NSC-34 cells. NASA, the Louise B. Stokes Alliance for Minority Participation (LSAMP),
and NINDS NIH AREA R15 grant supported this work. In addition, I appreciate the Honors
Program and the Zhan Undergraduate Research Scholars Program for encouraging me to
participate in research.

References

Akins, R Jr, McLaughlin T, Boyce R, Gilmour L, Gratton K. 2004. Exogenous metalloporphyrins
alter the organization and function of cultured neonatal rat heart cells via modulation of
heme oxygenase activity. J Cell. Physiol. 201: 26-34.
Bishop A, Yet SF, Lee ME, Perrella MA, Demple B. 2004. A key role for heme oxygenase-1 in
nitric oxide resistance in murine motor neurons and glia. BBRC 325: 3-9.
Bishop A, Anderson J. 2005. NO signaling in the CNS: from the physiological to the
pathological. Toxicology (Special Issue) Nitric Oxide, Cell Signaling and Death 208: 193205.
Bishop, A, Gooch R,Anderson J. 2006. Induced adaptive resistance to nitrooxidative stress in the
CNS: therapeutic implications. CNS Agents in Medicinal Chem. 6: 28 1-291.
Bishop A, Hobbs KG, Eguchi A, Jeffrey S, Smallwood L, Pennie C, Anderson J, Estkvez AG.
2009a. Differential sensitivity of oligodendrocytes and motor neurons to reactive nitrogen
species: implications for multiple sclerosis. J Neurochem. 109: 93- 104.
Bishop A, Gooch R, Eguchi A, Jeffrey S, Smallwood L, Anderson J, Estkvez AG. 2009b.
Mitigation of peroxynitrite-mediated nitric oxide (NO) toxicity as a mechanism of
induced adaptive NO resistance in the CNS. J Neurochem. 109: 74-84.
Eggett CJ, Crosier S, ,Manning P, Cookson MR, Mmenzies FM, McNeil CJ, Shaw PJ. 2000.
Development and characterisationof glutarnate-sensitive motor neuron cell line. J

Neurochem. 74: 1895-1902.
McLaurin J, Trudel GC, Shaw IT, Ante1 JP, Cashrnan NR. 1995. A human glial hybrid cell line
differentially expressing gens subserving oligodendrocyte and astrocyte phenotype. J

Neurobiol. 26: 283-293.

Pacher P, Beckman JS, Liaudet L. 2007. Nitric oxide and peroxynitrite in health and disease.
Physio. Rev.87:3 15-424.
Packer MA, Stasiv Y, Benraiss A, Chmieinicki E, Grinberg A, Westphal H, Goldman SA,
Enikolopov G. 2003. Nitric oxide negatively regulates mammalian adult neurogenesis.
Proc. Natl Acad Sci. USA 100: 9566-9571 .

